Treatment of Acute Promyelocytic Leukemia with Single-Agent Arsenic Trioxide
It is well recognized that arsenic trioxide (ATO) is an efficacious agent for the treatment of acute promyelocytic leukemia (APL). Use of single agent ATO in the treatment of APL leads to remissions which are durable in the majority. ATO is probably the most effective single agent in the treatment o...
| Main Authors: | , , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Università Cattolica del Sacro Cuore
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3248333/ |